Company / R&D per Share
Coherus Oncology, Inc. R&D per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.38
FY2019
5-year range
$0.94 / $3.54
FY2015-FY2019
Trend
-25.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.54 to $1.38 over the past 2 years.
Based on SEC 10-K filings.
1.38 in FY2019 with a 5-year CAGR of -28.2%.
Declined from $3.54 to $1.38 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -11.7%
- 5-Year CAGR
- -28.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, r&d per share decreased 25.1% year-over-year.
- Peak r&d per share was recorded in FY2014.
- Lowest r&d per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $1.38 | -25.1% |
| FY2018 | $1.84 | -48.0% |
| FY2017 | $3.54 | +76.8% |
| FY2016 | $2.01 | +113.2% |
| FY2015 | $0.94 | -87.0% |
| FY2014 | $7.21 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026